FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, announced today the appointment of Richard Gregg, M.D. as Chief Science Officer. Dr. Gregg comes to Vitae from Bristol Myers-Squibb where he was Vice President, Clinical Discovery, and was responsible for experimental medicine, clinical pharmacology and initial proof of concept activities for the company’s programs.
